Tag Archive: diabetic peripheral neuropathy

  1. Rising prevalence of peripheral neuropathy in pre-diabetes patients

    Leave a Comment

    Kirthi et al. just published a much needed systematic review looking at the rise of peripheral neuropathy in pre-diabetes patients. Not surprisingly, they noted a higher than expected prevalence of neuropathy in this patient population. Interestingly, abnormal small nerve fiber parameters were most notable in this group. This finding aligns with the current consensus that small fiber precedes large fiber degeneration in diabetes. They conclude, “Given the marked rise in pre-diabetes, further consideration of targeting screening in this population is required. Development of risk-stratification tools may facilitate earlier interventions.”


  2. Enhanced glucose control improves vibration perception thresholds in type 1 diabetes patients

    Leave a Comment

    Nice study by Dahlin et al. out of Sweden showed improved glucose control as measured by Hb A1c levels led to improved vibration perception threshold (VPT) in Type I diabetes patients. This is yet another paper implying improvement in neurological function is possible in those patients with diabetic peripheral neuropathy (DPN). This goes against long held dogma that DPN is largely irreversible. Interestingly, one of the more sensitive frequencies used in Dahlin’s study was 64 Hz, one of the frequencies available in our ETFMx.


  3. ETF Proof-of-Concept Study Cited in Two International Practice Guideline Documents

    Leave a Comment

    Although the International Federation of Diabetes (IDF) put out these clinical practice guidelines in 2017, we were gratified to see our 2014 ETF Proof-of-Concept study cited on page 19 of the document. We are cited in the section on using a 128 Hz tuning fork to assess diabetic peripheral neuropathy.

    We were equally excited to learn that this same article was cited in a more recent article in the European Journal of Vascular and Endovascular Surgery in July 2019. We were cited in Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia”.  This clinical practice guideline document cites us on page S31 discussing clinical testing for neuropathy. 


  4. New Study Recommends ETF as Best Choice in Vibration Testing for Diabetic Patients

    Leave a Comment

    We are excited to report the results of recently published research article utilizing the ETF. This study by Raymond et al. from the Journal of Diabetes Science and Technology has recommended the ETF as the best choice of vibration testing instruments to pair with Semmes-Weinstein monofilament testing when performing lower extremity sensation testing in diabetic patients.  This study protocol compared the ETF to the traditional 128 Hz tuning fork and biothesiometer in terms of ease of use, testing time and standardization of vibration output. The authors recommended the ETF over the other devices. We welcome the results of this study and look forward to more research papers validating the clinical use of the ETF.


  5. Evidence-based Links between Sympathetic Vascular Dysfunction and C-fiber Neuropathy

    Leave a Comment

    Researchers have long suspected a connection between sympathetic vascular dysfunction and small fiber neuropathy in diabetic patients. This is of special significance regarding the plantar skin of the foot where many diabetic complications arise. Several studies have found reduced vasomotor control to this skin in diabetics with diabetic peripheral neuropathy (DPN). Although the underlying mechanisms behind these observations remain to be elucidated, the connection appears consistent across varying patient populations and test protocols. The most prevalent hypothesis is that lack of proper neurological control results in abnormal vasomotor responses in the microcirculation of the skin.

    In particular, the normal vasoconstriction reflex present in healthy skin seen in response to external stimuli such as cold (1, 2), inspiratory gasp (3, 4) and dependent position (5, 6) has been shown to be muted or absent in patients with neuropathy. It has been suggested that small fiber neuropathy explains these findings; specifically, the C-fiber autonomic nerves responsible for controlling skin microcirculation. Studies investigating the vasomotor effects of the external stimuli noted above revealed an approximately 40% transient drop in skin blood flow consistent with vasoconstriction in healthy patients. This contrasts with observations in DPN patients where a muted or absent vasoconstriction reflex was recorded.

    The results of these studies have led researchers to posit various hypothetical explanations for the pathophysiological processes at work. Most of these point to the deep and complementary interplay of microangiopathic and neuropathic changes that occur in diabetes. Among other conclusions, their findings have direct implications for diabetic wound healing. Others studying microcirculatory dysfunction in diabetes have concluded that these difficult to heal wounds are functionally ischemic due to deficits in skin microcirculation (7). Some have also concluded that measurement of the vasoconstriction reflex could be a valid diagnostic method of quantifying small nerve fiber dysfunction. In particular, Bornmyr et al. (1, 2) have proposed a vasoconstriction index (VAC index*) as a test for small fiber nerve function in response to cold challenge. This approach would have the benefit of being non-invasive, objective and quantitative. Such a measurement would be welcome in clinical practice as small fiber neuropathy is notoriously difficult to quantify at point-of-care.

    *Vasoconstriction Index (healthy skin) = Skin blood flow after cold exposure/Skin blood flow before cold exposure = 0.6 average
    VAC Indices approaching 1.0 indicate impaired vasomotor response to cold exposure.


    1. Bornmyr S, Svensson H, Söderström T, Sundkvist G, Wollmer P. Finger skin blood flow in response to indirect cooling in normal subjects and in patients before and after sympathectomy. Clin Physiol. 1998 Mar;18(2):103-7.
    2. Holmlund F, Freccero C, Bornmyr S, Castenfors J, Johansson AM, Nordquist J, Sundkvist G, Svensson H, Wollmer P. Sympathetic skin vasoconstriction–further evaluation using laser Doppler techniques. Clin Physiol. 2001 May;21(3):287-91.
    3. Quattrini C, Harris ND, Malik RA, Tesfaye S. Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care. 2007 Mar;30(3):655-9.
    4. Aso Y, Inukai T, Takemura Y. Evaluation of skin vasomotor reflexes in response to deep inspiration in diabetic patients by laser Doppler flowmetry. A new approach to the diagnosis of diabetic peripheral autonomic neuropathy. Diabetes Care. 1997 Aug;20(8):1324-8.
    5. Midttun M, Snorgaard O. Heat-washout -an objective method for diagnosing neuropathy and atherosclerosis in diabetic patients.Clin Physiol Funct Imaging. 2013 Jul;33(4):302-6.
    6. Midttun M, Azad BB, Broholm R, Jensen LT, Svarer C, Jensen PE. Heat-washout measurements compared to distal blood pressure and perfusion in orthopaedic patients with foot ulcers. Clin Physiol Funct Imaging. 2017 Jan;37(1):79-83.
    7. Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care. 2001 Feb;24(2):344-9.